Attached files

file filename
8-K - FORM 8-K - PRGX GLOBAL, INC.d343148d8k.htm

Exhibit 99.1

 

LOGO

Press Release

PRGX Global, Inc. Announces First Quarter

2012 Financial Results

Operating Highlights

 

 

Q1 revenues of $51.6M represents 1.8% growth over Q1 2011; 3.4% growth over Q4 2011

 

 

Q1 Adjusted EBITDA of $6.8 million represents 23% growth over Q1 2011; 5.9% growth over Q4 2011

 

 

New Services revenues of $8.5 million represents 25% growth over Q1 2011; 53% growth over Q4 2011

 

 

New Services positive Adjusted EBITDA represents important milestone in growth strategy

ATLANTA, April 30, 2012 — PRGX Global, Inc. (Nasdaq:PRGX), the world’s leading provider of recovery audit services and the pioneer in Profit Discovery™, today announced its unaudited financial results for the first quarter ended March 31, 2012.

“I am pleased to report year-over-year quarterly growth, particularly in light of our very strong performance in the first quarter last year,” said Romil Bahl, president and chief executive officer. “The PRGX team continues to demonstrate that our growth strategy remains on track.”

“Our growth strategy also continues to drive improved bottom line results. Our focus on reducing costs using our proprietary technology and global shared services model helped us deliver over $1 million more in Adjusted EBITDA this quarter compared to Q1 2011,” said Bahl.

“Each of our service segments is gathering steam. The Accounts Payable Recovery Audit core continues to increase its client count, take share in key geographies, and improve operating margins through our cost-to-serve reduction program. Our Healthcare Claims Recovery Audit business just delivered its best quarter since the launch of our growth strategy, validating our entrée into the large and rapidly expanding market for services targeting healthcare Fraud, Waste & Abuse. And finally, our Analytics & Advisory Profit Optimization services are recovering from the weakness encountered late last year and remain a tremendous growth opportunity for the Company over the coming three to five years,” concluded Bahl.

Consolidated Results for Three Months Ended March 31, 2012

Consolidated revenues for the first quarter of 2012 were $51.6 million compared to $50.7 million in the same prior year period. After adjusting for changes in foreign exchange rates, consolidated first quarter revenues in 2012 increased 2.9% compared to the same period in 2011.

 

1


LOGO

 

Recovery Audit Services – Americas revenues for the first quarter of 2012 decreased 1.0% to $28.8 million compared to $29.1 million in the same period in the prior year. On a constant dollar basis, adjusted for changes in foreign exchange rates, Recovery Audit Services – Americas revenues decreased by 0.2% compared to 2011.

Recovery Audit Services – Europe Asia/Pacific revenues for the first quarter of 2012 decreased 3.0% to $14.3 million compared to $14.8 million in the same period in the prior year. On a constant dollar basis, adjusted for changes in foreign exchange rates, Recovery Audit Services – Europe Asia/Pacific revenues decreased by 1.4% compared to 2011.

New Services revenues for the first quarter of 2012 increased 25% to $8.5 million compared to $6.9 million in the same period in the prior year. The New Services segment represents Healthcare Claims Recovery Audit services and our Profit Optimization services.

Total cost of revenues for the first quarter of 2012 were $34.2 million, or 66.3% of revenue, compared to $34.6 million, or 68.2% of revenue, in the same period in the prior year. Cost of revenues as a percentage of revenue declined in all three of the Company’s reporting segments. SG&A for the first quarter of 2012 was $12.6 million compared to $12.4 million in the first quarter of 2011, 24.5% of revenue in each period. Depreciation and amortization expenses amounted to $3.8 million in the first quarter of 2012 compared to $2.3 million in the prior year first quarter. The increases in depreciation and amortization expenses are primarily attributable to the additional amortization charges resulting from the BSI acquisition in December 2011 and an associate migration in the UK completed in January 2012.

Net earnings for the first quarter of 2012 were $0.3 million, or $0.01 per basic and diluted share, compared to net earnings of $0.4 million, or $0.02 per basic and diluted share, for the same period in 2011. Net cash provided by operating activities for the first quarter of 2012 was $2.0 million compared to $6.2 million in the first quarter of 2011. The decrease in net cash provided by operating activities is due primarily to payments made in the first quarter of 2012 for incentive compensation, with no comparable amounts paid in the first quarter of 2011.

Adjusted EBITDA for the first quarter of 2012 was $6.8 million compared to $5.5 million of Adjusted EBITDA for the same period in 2011. The 2012 first quarter Adjusted EBITDA is earnings before interest, taxes, depreciation and amortization (EBITDA) excluding a charge of $1.4 million related to stock-based compensation, $0.2 million of transformation severance and related expenses, a $0.1 million charge for acquisition obligations classified as compensation, $0.2 million in legal fees relating to an overtime pay claim, and $0.3 million of foreign currency gains on intercompany balances. The comparable Adjusted EBITDA amount for the first quarter of 2011 excludes from EBITDA for such period a $0.9 million charge for stock-based compensation, $0.8 million of transformation severance and related expenses, a $0.1 million charge for acquisition obligations classified as compensation and $0.4 million of foreign currency gains on intercompany balances. Schedule 3 attached to this press release provides a reconciliation of net earnings to each of EBIT, EBITDA and Adjusted EBITDA.

 

2


LOGO

 

Liquidity

At March 31, 2012, the Company had unrestricted cash and cash equivalents of $18.2 million and had no borrowings against its revolving credit facility. Bank debt outstanding at quarter end was $8.3 million, which represented the outstanding balance on a variable rate term loan due quarterly through 2014.

First Quarter Earnings Call

As previously announced, management will hold a conference call tomorrow morning at 8:30 AM (Eastern time) to discuss the Company’s first quarter 2012 financial results. To access the conference call, listeners in the U.S. and Canada should dial (877) 755-7423 at least 5 minutes prior to the start of the conference. Listeners outside the U.S. and Canada should dial (678) 894-3069. To be admitted to the call, listeners should use passcode 74568195.

This teleconference will also be audiocast on the Internet at www.prgx.com (click on “Events & Presentations” under “Investors”). A replay of the audiocast will be available at the same location on www.prgx.com beginning approximately two hours after the conclusion of the live audiocast, extending through June 30, 2012. Please note that the Internet audiocast is “listen-only.” Microsoft Windows Media Player is required to access the live audiocast and the replay and can be downloaded from www.microsoft.com/windows/mediaplayer.

About PRGX Global, Inc.

Headquartered in Atlanta, Georgia, PRGX Global, Inc. is the world’s leading provider of recovery audit services. With over 1,600 employees, the Company operates and serves clients in more than 30 countries and provides its services to over 75% of the top 30 global retailers. PRGX is also pioneering Profit Discovery™, a unique combination of audit, analytics and advisory services that improves client financial performance. For additional information, please visit PRGX at www.prgx.com.

Non-GAAP Financial Measures

EBIT, EBITDA and Adjusted EBITDA are all “non-GAAP financial measures” presented as supplemental measures of the Company’s performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating its performance over time, and that the rating agencies and a number of lenders use EBITDA and similar measures for similar purposes. In addition, a measure similar to Adjusted EBITDA is used in the restrictive covenants contained in the Company’s secured credit facility. However, EBIT, EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of the Company’s results as reported under GAAP. In addition, in evaluating EBIT, EBITDA and Adjusted EBITDA, you should be aware that, as described above, the adjustments may vary from period to period and in the future the Company will incur expenses such as those used in calculating these measures. The Company’s presentation of these measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. Schedule 3 to this press release provides a reconciliation of net earnings to each of EBIT, EBITDA and Adjusted EBITDA.

 

3


LOGO

 

Forward-Looking Statements

In addition to historical information, this press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include both implied and express statements regarding the Company’s financial condition and revenue growth, business development efforts, and the success of its growth strategies and expansion into new markets, including anticipated opportunities in the healthcare industry. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the historical results or from any results expressed or implied by such forward-looking statements. Risks that could affect the Company’s future performance include revenues that do not meet expectations or justify costs incurred, the Company’s ability to develop material sources of new revenue in addition to revenues from its core recovery audit services, changes in the market for the Company’s services, the Company’s ability to retain and attract qualified personnel, changes to Medicare and Medicaid recovery audit contractor programs, the Company’s ability to integrate recent and future acquisitions, uncertainty in the credit markets, the Company’s ability to maintain compliance with its financial covenants, client bankruptcies, loss of major clients, and other risks generally applicable to the Company’s business. For a discussion of other risk factors that may impact the Company’s business, please see the Company’s filings with the Securities and Exchange Commission, including its Form 10-K filed on March 15, 2012. The Company disclaims any obligation or duty to update or modify these forward-looking statements.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: PRGX Global, Inc.

CONTACT: PRGX Global, Inc.

investor-relations@prgx.com

Phone: 770-779-3011

 

4


LOGO

 

SCHEDULE 1

PRGX Global, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(Amounts in thousands, except per share data)

(Unaudited)

 

     Three Months
Ended March 31,
 
     2012     2011  

Revenues

   $ 51,649      $ 50,718   

Operating expenses:

    

Cost of revenues

     34,218        34,594   

Selling, general and administrative expenses

     12,637        12,430   

Depreciation of property and equipment

     1,513        1,181   

Amortization of intangible assets

     2,327        1,121   
  

 

 

   

 

 

 

Total operating expenses

     50,695        49,326   
  

 

 

   

 

 

 

Operating income

     954        1,392   

Foreign currency transaction gains on short-term intercompany balances

     (339     (448

Interest expense, net

     504        347   
  

 

 

   

 

 

 

Earnings before income taxes

     789        1,493   
  

 

 

   

 

 

 

Income tax expense

     497        1,121   
  

 

 

   

 

 

 

Net earnings

   $ 292      $ 372   
  

 

 

   

 

 

 

Basic earnings per common share

   $ 0.01      $ 0.02   
  

 

 

   

 

 

 

Diluted earnings per common share

   $ 0.01      $ 0.02   
  

 

 

   

 

 

 

Weighted average common shares outstanding:

    

Basic

     25,309        24,258   
  

 

 

   

 

 

 

Diluted

     25,765        24,533   
  

 

 

   

 

 

 

 

5


LOGO

 

SCHEDULE 2

PRGX Global, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(Amounts in thousands)

(Unaudited)

 

     March 31,
2012
    December 31,
2011
 
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 18,192      $ 20,337   

Restricted cash

     123        64   

Receivables:

    

Contract receivables, net

     40,341        40,624   

Employee advances and miscellaneous receivables, net

     1,099        1,343   
  

 

 

   

 

 

 

Total receivables

     41,440        41,967   

Prepaid expenses and other current assets

     4,090        5,594   
  

 

 

   

 

 

 

Total current assets

     63,845        67,962   

Property and equipment, net

     19,168        18,586   

Goodwill

     13,876        13,194   

Intangible assets, net

     22,329        23,406   

Deferred income taxes

     849        831   

Other assets

     1,921        2,434   
  

 

 

   

 

 

 

Total assets

   $ 121,988      $ 126,413   
  

 

 

   

 

 

 
LIABILITIES AND SHAREHOLDERS’ EQUITY     

Current liabilities:

    

Accounts payable and accrued expenses

   $ 14,789      $ 15,035   

Accrued payroll and related expenses

     16,930        21,920   

Refund liabilities and deferred revenue

     8,565        8,434   

Current portion of debt

     3,000        3,000   

Business acquisition obligations

     6,349        3,502   
  

 

 

   

 

 

 

Total current liabilities

     49,633        51,891   

Long-term debt

     5,250        6,000   

Noncurrent business acquisition obligations

     2,571        5,604   

Other long-term liabilities

     3,523        3,828   
  

 

 

   

 

 

 

Total liabilities

     60,977        67,323   
  

 

 

   

 

 

 

Shareholders’ equity:

    

Common stock

     251        251   

Additional paid-in capital

     575,479        574,266   

Accumulated deficit

     (518,300     (518,592

Accumulated other comprehensive income

     3,581        3,165   
  

 

 

   

 

 

 

Total shareholders’ equity

     61,011        59,090   
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 121,988      $ 126,413   
  

 

 

   

 

 

 

 

6


LOGO

 

SCHEDULE 3

PRGX Global, Inc. and Subsidiaries

Reconciliation of Net Earnings to EBIT, EBITDA and Adjusted EBITDA

(Amounts in thousands)

(Unaudited)

 

     Three Months
Ended March 31,
 
     2012     2011  

Reconciliation of net earnings to EBIT, EBITDA and Adjusted EBITDA:

            

Net earnings

   $ 292      $ 372   

Income tax expense

     497        1,121   

Interest expense, net

     504        347   
  

 

 

   

 

 

 

EBIT

     1,293        1,840   

Depreciation of property and equipment

     1,513        1,181   

Amortization of intangible assets

     2,327        1,121   
  

 

 

   

 

 

 

EBITDA

     5,133        4,142   

Foreign currency transaction gains on short-term intercompany balances

     (339     (448

Acquisition obligations classified as compensation

     101        97   

Transformation severance and related expenses

     242        827   

Legal fees for overtime pay claim

     249        —     

Stock-based compensation

     1,401        901   
  

 

 

   

 

 

 

Adjusted EBITDA

   $ 6,787      $ 5,519   
  

 

 

   

 

 

 

EBIT, EBITDA and Adjusted EBITDA are all “non-GAAP financial measures” presented as supplemental measures of our performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating the Company’s performance over time, and that the rating agencies and a number of lenders use EBIT, EBITDA and similar measures for similar purposes. In addition, a measure similar to Adjusted EBITDA is used in the restrictive covenants contained in the Company’s secured credit facility. However, EBIT, EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under GAAP. In addition, in evaluating EBIT, EBITDA and Adjusted EBITDA, you should be aware that in the future we will incur expenses such as those used in calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

 

7


LOGO

 

SCHEDULE 4

PRGX Global, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Amounts in thousands)

(Unaudited)

 

     Three Months
Ended March 31,
 
     2012     2011  

Cash flows from operating activities:

    

Net earnings

   $ 292      $ 372   

Adjustments to reconcile net earnings to net cash provided by operating activities:

    

Depreciation and amortization

     3,840        2,302   

Amortization of deferred debt costs

     46        45   

Stock-based compensation expense

     1,401        901   

Foreign currency transaction gains on short-term intercompany balances

     (339     (448

Increase in receivables

     1,187        634   

Increase (decrease) in accounts payable, accrued payroll and other accrued expenses

     (5,482     3,127   

Other, primarily changes in assets and liabilities

     1,029        (779
  

 

 

   

 

 

 

Net cash provided by operating activities

     1,974        6,154   
  

 

 

   

 

 

 

Cash flows used in investing activities:

    

Business acquisitions

     (997     —     

Purchases of property and equipment, net of disposals

     (1,967     (1,479
  

 

 

   

 

 

 

Net cash used in investing activities

     (2,964     (1,479
  

 

 

   

 

 

 

Net cash used in financing activities

     (1,571     (859

Effect of exchange rates on cash and cash equivalents

     416        403   
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     (2,145     4,219   

Cash and cash equivalents at beginning of period

     20,337        18,448   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 18,192      $ 22,667   
  

 

 

   

 

 

 

 

8


LOGO

 

SCHEDULE 5

PRGX Global, Inc. and Subsidiaries

Results by Operating Segment *

(Amounts in thousands)

(Unaudited)

 

     Three Months Ended
March 31,
 
     2012     2011     Change  

Revenues

      

Recovery Audit Services - Americas

   $ 28,813      $ 29,113      $ (300

Recovery Audit Services - Europe/Asia-Pacific

     14,305        14,752        (447

New Services

     8,531        6,853        1,678   
  

 

 

   

 

 

   

 

 

 

Total

   $ 51,649      $ 50,718      $ 931   
  

 

 

   

 

 

   

 

 

 

Cost of revenues

      

Recovery Audit Services - Americas

   $ 15,952      $ 16,643      $ 691   

Recovery Audit Services - Europe/Asia-Pacific

     11,075        11,590        515   

New Services

     7,191        6,361        (830
  

 

 

   

 

 

   

 

 

 

Total

   $ 34,218      $ 34,594      $ 376   
  

 

 

   

 

 

   

 

 

 

Selling, general and administrative expenses

      

Recovery Audit Services - Americas

   $ 4,862      $ 5,376      $ 514   

Recovery Audit Services - Europe/Asia-Pacific

     1,251        1,163        (88

New Services

     1,397        1,228        (169

Corporate

     5,127        4,663        (464
  

 

 

   

 

 

   

 

 

 

Total

   $ 12,637      $ 12,430      $ (207
  

 

 

   

 

 

   

 

 

 

Depreciation of property and equipment

      

Recovery Audit Services - Americas

   $ 915      $ 774      $ (141

Recovery Audit Services - Europe/Asia-Pacific

     40        88        48   

New Services

     558        319        (239
  

 

 

   

 

 

   

 

 

 

Total

   $ 1,513      $ 1,181      $ (332
  

 

 

   

 

 

   

 

 

 

Amortization of intangible assets

      

Recovery Audit Services - Americas

   $ 1,586      $ 573      $ (1,013

Recovery Audit Services - Europe/Asia-Pacific

     539        332        (207

New Services

     202        216        14   
  

 

 

   

 

 

   

 

 

 

Total

   $ 2,327      $ 1,121      $ (1,206
  

 

 

   

 

 

   

 

 

 

Operating income (loss)

      

Recovery Audit Services - Americas

   $ 5,498      $ 5,747      $ (249

Recovery Audit Services - Europe/Asia-Pacific

     1,400        1,579        (179

New Services

     (817     (1,271     454   

Corporate

     (5,127     (4,663     (464
  

 

 

   

 

 

   

 

 

 

Total

   $ 954      $ 1,392      $ (438
  

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

      

Recovery Audit Services - Americas

   $ 8,338      $ 7,761      $ 577   

Recovery Audit Services - Europe/Asia-Pacific

     2,036        2,159        (123

New Services

     139        (639     778   

Corporate

     (3,726     (3,762     36   
  

 

 

   

 

 

   

 

 

 

Total

   $ 6,787      $ 5,519      $ 1,268   
  

 

 

   

 

 

   

 

 

 

 

* The Recovery Audit Services - Americas segment represents recovery audit services, excluding New Services, provided in the United States, Canada and Latin America. The Recovery Audit Services - Europe/Asia-Pacific segment represents recovery audit services provided in Europe, Asia and the Pacific region. The New Services segment represents services provided to healthcare organizations (including recovery audit services), financial advisory services and business analytics services.

 

9